Literature DB >> 26355569

Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1.

John K Bui1, John W Mellors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26355569     DOI： 10.1097/QAD.0000000000000788

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

Review 1.  CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination.

Authors:  Klaus Früh; Louis Picker
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

Review 2.  Impact of Myeloid Reservoirs in HIV Cure Trials.

Authors:  Brooks I Mitchell; Elizabeth I Laws; Lishomwa C Ndhlovu
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

3.  Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection.

Authors:  Christian Deo T Deguit; Michelle Hough; Rebecca Hoh; Melissa Krone; Christopher D Pilcher; Jeffrey N Martin; Steven G Deeks; Joseph M McCune; Peter W Hunt; Rachel L Rutishauser
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

Review 4.  Strategies to target non-T-cell HIV reservoirs.

Authors:  Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

Review 5.  Barriers to HIV remission research in low- and middle-income countries.

Authors:  Theresa Rossouw; Joseph D Tucker; Gert U van Zyl; Kenly Sikwesi; Catherine Godfrey
Journal:  J Int AIDS Soc       Date:  2017-06-05       Impact factor: 5.396

6.  Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells.

Authors:  John K Bui; Elias K Halvas; Elizabeth Fyne; Michele D Sobolewski; Dianna Koontz; Wei Shao; Brian Luke; Feiyu F Hong; Mary F Kearney; John W Mellors
Journal:  PLoS Pathog       Date:  2017-02-22       Impact factor: 6.823

7.  T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell.

Authors:  Sai Liu; Jianping Sun; Zhen Li; Ling Qin; Guihai Liu; Kang Li; Hao Wu; Tao Dong; Yonghong Zhang
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

8.  Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART.

Authors:  John K Bui; Joshua C Cyktor; Elizabeth Fyne; Shalyn Campellone; Stephen W Mason; John W Mellors
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.